Bausch Health Financials

Bausch Health Stock Summary

Bausch Health competes with Highlight Communications, Charter Communications, GEELY AUTOMOBILE, Cairo Communication, and SBA Communications. Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada. BAUSCH HEALTH operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21100 people.

Bausch Health Key Financial Ratios

There are many critical financial ratios that Bausch Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bausch Health Companies reports annually and quarterly.

Bausch Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bausch Health's current stock value. Our valuation model uses many indicators to compare Bausch Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bausch Health competition to find correlations between indicators driving Bausch Health's intrinsic value. More Info.Bausch Health Companies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bausch Health's earnings, one of the primary drivers of an investment's value.

Bausch Health Companies Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Bausch Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bausch Health Companies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bausch Health Companies based on widely used predictive technical indicators. In general, we focus on analyzing Bausch Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bausch Health's daily price indicators and compare them against related drivers.

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.